208 related articles for article (PubMed ID: 18439434)
1. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
Cenini G; Sultana R; Memo M; Butterfield DA
Free Radic Biol Med; 2008 Jul; 45(1):81-5. PubMed ID: 18439434
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
[TBL] [Abstract][Full Text] [Related]
4. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
[TBL] [Abstract][Full Text] [Related]
5. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
[TBL] [Abstract][Full Text] [Related]
6. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA
J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
Sultana R; Reed T; Perluigi M; Coccia R; Pierce WM; Butterfield DA
J Cell Mol Med; 2007; 11(4):839-51. PubMed ID: 17760844
[TBL] [Abstract][Full Text] [Related]
9. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
[TBL] [Abstract][Full Text] [Related]
10. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
11. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
Sultana R; Perluigi M; Newman SF; Pierce WM; Cini C; Coccia R; Butterfield DA
Antioxid Redox Signal; 2010 Mar; 12(3):327-36. PubMed ID: 19686046
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
13. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
[TBL] [Abstract][Full Text] [Related]
14. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
15. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
16. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
Huang Q; Aluise CD; Joshi G; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
J Neurosci Res; 2010 Sep; 88(12):2618-29. PubMed ID: 20648652
[TBL] [Abstract][Full Text] [Related]
17. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
[TBL] [Abstract][Full Text] [Related]
18. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment.
Sultana R; Piroddi M; Galli F; Butterfield DA
Neurochem Res; 2008 Dec; 33(12):2540-6. PubMed ID: 18320305
[TBL] [Abstract][Full Text] [Related]
19. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
Di Domenico F; Owen JB; Sultana R; Sowell RA; Perluigi M; Cini C; Cai J; Pierce WM; Butterfield DA
J Neurosci Res; 2010 Dec; 88(16):3566-77. PubMed ID: 20936705
[TBL] [Abstract][Full Text] [Related]
20. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.
Sultana R; Butterfield DA
J Bioenerg Biomembr; 2009 Oct; 41(5):441-6. PubMed ID: 19777328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
